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Introduction
Seizure as a symptom of withdrawal from
benzodiazepines is uncommon but well recognized.
In one series, none of the 22 patients undergoing
withdrawal from benzodiazepines developed
seizure1. In another series, no seizure was observed
in 57 benzodiazepine-dependent patients undergoing
abrupt discontinuation from benzodiazepine2. In
fact, most of the cases were described in case
reports. It was found that factors like duration of
dependence, short half-life, high dosage, abrupt
discontinuation and concurrent multiple drug use
were important for the development of seizure. In
the following report, three episodes of drug
withdrawal in a Chinese lady dependent on
benzodiazepines were described. Generalized tonic-
clonic seizures were present as withdrawal
symptoms but only in two of these episodes.
Several clinical and pharmacological features are
discussed to highlight how they interact and give
rise to benzodiazepine withdrawal seizure. The
present report also discusses how a change in the
availability of benzodiazepines with the tightened
legislation contributed to the occurrence of the
withdrawal seizures.
Case Report
C, a 31-year-old divorced Chinese lady
suffering from chronic primary insomnia, started
taking a benzodiazepine hypnotic seven years ago
when her husband deserted her. Her work as a
nightclub hostess finished at 3am and she took
flunitrazepam (Rohypnol) 2-4mg to make herself
fall asleep 'quick and smooth'. Her tolerance to
flunitrazepam increased gradually through these
years. She needed to take flunitrazepam 8-12mg to
induce sleep. Besides she also took
dextromethorphen hydrobromide (Romilar), an
anti-tussive tablet, 15-30mg, or 2-3 bottles of beer
(Carlsberg) every now and then, in addition to
flunitrazepam, to get herself to sleep. She did not
experience any tolerance, withdrawal symptoms or
craving for alcohol or the cough tablets however.
There was no history of psychiatric illness,
personality disorder, substance misuse or epilepsy in
her family. She enjoyed good health all along. She
received an education up to primary level only but
was regarded by family members as intelligent and
independent. She was outgoing, optimistic and
hardworking. She had good social support from her
brothers and mother, the latter actually helped in
looking after her 3 children.
Before her first episode of withdrawal seizure,
she felt fed up with her lifestyle as a nightclub
hostess. She quit her job and stopped all her
medication and alcohol straight away. She became
tense, anxious, tremulous and unable to fall asleep.
She had a generalized tonic-clonic seizure while she
was having a barbecue picnic with her family on the
seventh day after she stopped her benzodiazepine
hypnotic. She was incontinent of urine but not of
stool. She was violent and delirious on admission
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and required restraint and sedation. She became
emotionally stable after 1 week and the EEG before
discharge from hospital was normal.
She stopped substance misuse for 1 year during
which she cohabitated with a married man and gave
birth to a child. She started taking benzodiazepines
again when she found out that the man decided not
to divorce his wife. She could not fall asleep at
night unless she took alprazolam (Xanax) 1.25-
1.5mg. She also had craving for the drug during the
day time when she felt frustrated or bored. This
continued for 6 months when she decided to stop
all her medication. She consulted a drug misuse
counselling center and was advised to undergo in-
patient detoxification bearing in mind her previous
history of withdrawal seizure. She was later
admitted to a mental hospital. She refused gradual
tapering of her drug and insisted on a 'cold turkey'
detoxification. She failed to get any sleep during
the first 72 hours and experienced fatiguability,
anxiety and blurring of vision. There was no muscle
twitching or seizure. She was successfully detoxified
in 12 days. She was calm and relaxed with no
craving on discharge.
She stopped substance misuse for another year,
but when she found her new boyfriend and
cohabitant secretly having affairs with other women
she started taking benzodiazepines again. She took
brotizolam (Lendormin) up to 2 mg per day. She
would crave for the drug during the day when
frustrated and would become anxious and tremulous
if she resisted to take the drug. Her tolerance
gradually increased over 6 months during which she
had episodes of taking brotizolam 5 mg without any
sign of intoxication. After a while, she was unable
to buy the medication when the Government
classified it as a dangerous drug. She experienced
insomnia, craving for the drug, anxiety and muscle
twitching. On the fourth day, she developed a
generalized tonic-clonic seizure. Blood assay for
brotizolam was negative. EEG on admission
showed generalized spikes. She slept well and
remained calm throughout the detoxication and was
discharged after one week. EEG done after
discharge was normal.
Discussion
Seizures following abrupt discontinuation of
benzodiazepines are uncommon but well
recognized. A few factors such as the use of higher
than therapeutic dosage for long periods of time3'4
and abrupt withdrawal5 contributed to withdrawal
seizures in this patient. The regular use of alcohol
may also have contributed to the withdrawal seizure
although reports have only shown the association in
patients who are dependent on alcohol6. In
addition, the concurrent use of other sedative
hypnotics or other psychotropic drugs that lower
seizure threshold, such as neuroleptic and tricyclic
antidepressants7, may explain the withdrawal seizure
in this patient as she belonged to the group of
patients who might have multiple psychotropic drug
misuse; but it was not always possible to get a
positive confirmation in the history.
It is interesting that she stopped
benzodiazepines abruptly for 3 times and had a
seizure on only 2 occasions. There were at least
two possible reasons. Firstly, she used
flunitrazepam and brotizolam up to 10 times of the
therapeutic dosage resulting in withdrawal seizure
but she took alprazolam within the therapeutic
range, the abrupt discontinuation of which did not
result in a withdrawal seizure. Secondly, it was
shown that maintenance of alertness and relaxation
could sometimes inhibit a seizure8. The patient was
admitted to hospital and psychologically prepared
for the withdrawal of alprazolam which may
contribute to the absence of withdrawal seizure.
Another interesting feature was that the
withdrawal seizures occurred at Day 7 for
flunitrazepam and at Day 4 for brotizolam upon
discontinuation. Most reports found that
withdrawal seizures usually occurred within 1 to 3
days of discontinuing benzodiazepines3'4 9' It was
especially unusual since brotizolam and its
metabolites had an elimination half life of only 3.6
to 7.9 hours10. However, some reports also noticed
that withdrawal seizures might occur after a week
or more following discontinuation3'11 of
benzodiazepines.
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In 1990, the Dangerous Drug Ordinance in
Hong Kong classified 3 kinds of widely abused
benzodiazepines as dangerous drugs and one of
them is brotizolam. Before the enforcement of
legislation, brotizolam was easily available over-the-
counter. The reduced availability of
benzodiazepines and the adverse publicity on their
effects will increase the worries about their long
term effects among people who are dependent on
benzodiazepines. They may abruptly stop the drug
and have the risk of withdrawal seizures especially
among those taking high doses as described in this
report. The author hopes to draw the attention of
medical practitioners to the risk among patients
dependent on benzodiazepines. Patients should be
helped to undergo detoxification in the proper
manner. This involves gradual withdrawal
combined with supportive counselling. Anxiety
management may be needed for patients who
cannot give up the drug with simple measures
alone. Underlying psychiatric problems should be
given specific treatment. In some patients, with
high risk of complications as discussed above, an in-
patient detoxification programme is indicated. I
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WORLD LEADERS IN MEDICAL SCIENCES
TO CONVENE IN HONG KONG
Medical Update Conference 1992 — will bring a unique grouping of world leaders in all fields of
medicine from Australia plus a number of Hong Kong's most distinguished medical authorities to discuss
the latest developments with their colleagues in Hong Kong for four days, starting on August 15, 1992 at
the Shangri-La Hotel, Kowloon.
A separate conference on Practice Management — of special value to support staff of Hong Kong's
General Practitioners — will run concurrently with the ESMA Medical Update Conference.
Enquiries from Hong Kong can be Faxed on International Dialling to: Dr. Edward P. Kremer,
Conference Convener, 61-2-365 2390.
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